Table II.
Item | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
---|---|---|---|---|---|
Age, years | 55 | 93 | 60 | 62 | 76 |
Sex | Male | Female | Female | Male | Male |
Location | iCCA | dCCA | dCCA | pCCA | ampCA |
Previous history of cancer | None | None | None | None | None |
Family history | None | None | None | None | None |
Immunohistochemistry | dMLH1/PMS2 | dMSH2/MSH6 | dMSH6 | dPMS2 | dPMS2 |
MSS status | MSI-H | MSI-H | Unmeasurable | MSS | MSS |
BAT-25 | + | + | − | − | |
BAT-26 | + | + | − | − | |
NR-21 | + | + | − | − | |
MONO-27 | + | − | − | − | |
NR-24 | + | + | − | − | |
Main differentiation | Well | Moderate | Poor | Well | Moderate |
UICC stage | 2 | 3A | 1 | 3C | 3A |
Resection margin | 0 | 0 | 1 | 0 | 0 |
Recurrence (location) | + (Lymph node) | − | − | + (Pulmonary) | − |
Overall survival, months | 17 | 6 | 48 | 37 | 34 |
Circumstance of death | DOD | DID | DID | DOD | DID |
UICC, Union for International Cancer Control; CCA, cholangiocarcinoma; iCCA, intrahepatic CCA; pCCA, perihilar CCA; dCCA, distal CCA; ampCA, ampullary carcinoma; d, defective; MLH1, mutL homolog 1; PMS2, mismatch repair endonuclease PMS2; MSH, MutS homolog; MSI-H, microsatellite instability-high; MSS, microsatellite stability; DOD, died of disease; DID, died with intercurrent disease.